Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in ...

Fungal infections are becoming deadlier as drug resistance spreads and treatment options stall. Researchers at McMaster University discovered that a molecule called butyrolactol A can dramatically ...

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

At the end of 2022, the last year for which CDC data was publicly available, there were 135,400 people living with HIV in ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...

An AIDS drug already shown to help prevent spread of the virus in gay men also works for heterosexual men and women, two studies in Africa found.

Over 10,000 Floridians are losing HIV medication due to a supposed shortfall in the state budget. Democratic Party Chair ...

Until last year, the number of children orphaned because a parent died from AIDS, was plummeting. That's thanks to America's 20 year effort to get lifesaving HIV meds to millions in need. But last ...

This study uses Population-based HIV Impact Assessments survey data to examine factors associated with gender disparities in ...

Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...